| Record Information |
|---|
| Version | 5.0 |
|---|
| Status | Detected but not Quantified |
|---|
| Creation Date | 2012-09-06 21:03:01 UTC |
|---|
| Update Date | 2023-02-21 17:18:37 UTC |
|---|
| HMDB ID | HMDB0028929 |
|---|
| Secondary Accession Numbers | |
|---|
| Metabolite Identification |
|---|
| Common Name | Leucyl-Glycine |
|---|
| Description | Leucyl-Glycine is a dipeptide composed of leucine and glycine. It is an incomplete breakdown product of protein digestion or protein catabolism. Some dipeptides are known to have physiological or cell-signaling effects although most are simply short-lived intermediates on their way to specific amino acid degradation pathways following further proteolysis. This dipeptide has not yet been identified in human tissues or biofluids and so it is classified as an 'Expected' metabolite. |
|---|
| Structure | InChI=1S/C8H16N2O3/c1-5(2)3-6(9)8(13)10-4-7(11)12/h5-6H,3-4,9H2,1-2H3,(H,10,13)(H,11,12) |
|---|
| Synonyms | | Value | Source |
|---|
| L-g Dipeptide | HMDB | | L-Leucyl-L-glycine | HMDB | | Leu-gly | HMDB, MeSH | | Leucine glycine dipeptide | HMDB | | Leucine-glycine dipeptide | HMDB | | Leucylglycine | HMDB, MeSH | | LG Dipeptide | HMDB | | Glycyl-L-leucine | MeSH, HMDB | | Glycylleucine | MeSH, HMDB | | Glycylleucine, (D)-isomer | MeSH, HMDB | | Gly-leu | MeSH, HMDB | | 2-[(2-Amino-1-hydroxy-4-methylpentylidene)amino]acetate | Generator, HMDB |
|
|---|
| Chemical Formula | C8H16N2O3 |
|---|
| Average Molecular Weight | 188.2242 |
|---|
| Monoisotopic Molecular Weight | 188.116092388 |
|---|
| IUPAC Name | 2-(2-amino-4-methylpentanamido)acetic acid |
|---|
| Traditional Name | (2-amino-4-methylpentanamido)acetic acid |
|---|
| CAS Registry Number | Not Available |
|---|
| SMILES | CC(C)CC(N)C(=O)NCC(O)=O |
|---|
| InChI Identifier | InChI=1S/C8H16N2O3/c1-5(2)3-6(9)8(13)10-4-7(11)12/h5-6H,3-4,9H2,1-2H3,(H,10,13)(H,11,12) |
|---|
| InChI Key | LESXFEZIFXFIQR-UHFFFAOYSA-N |
|---|
| Chemical Taxonomy |
|---|
| Description | Belongs to the class of organic compounds known as dipeptides. These are organic compounds containing a sequence of exactly two alpha-amino acids joined by a peptide bond. |
|---|
| Kingdom | Organic compounds |
|---|
| Super Class | Organic acids and derivatives |
|---|
| Class | Carboxylic acids and derivatives |
|---|
| Sub Class | Amino acids, peptides, and analogues |
|---|
| Direct Parent | Dipeptides |
|---|
| Alternative Parents | |
|---|
| Substituents | - Alpha-dipeptide
- Leucine or derivatives
- N-acyl-alpha-amino acid
- N-acyl-alpha amino acid or derivatives
- Alpha-amino acid amide
- Alpha-amino acid or derivatives
- Fatty amide
- N-acyl-amine
- Fatty acyl
- Amino acid or derivatives
- Carboxamide group
- Amino acid
- Secondary carboxylic acid amide
- Monocarboxylic acid or derivatives
- Carboxylic acid
- Hydrocarbon derivative
- Organic oxygen compound
- Organic oxide
- Primary aliphatic amine
- Organopnictogen compound
- Organic nitrogen compound
- Carbonyl group
- Organonitrogen compound
- Organooxygen compound
- Primary amine
- Amine
- Aliphatic acyclic compound
|
|---|
| Molecular Framework | Aliphatic acyclic compounds |
|---|
| External Descriptors | Not Available |
|---|
| Ontology |
|---|
| Not Available | Not Available |
|---|
| Physical Properties |
|---|
| State | Solid |
|---|
| Experimental Molecular Properties | | Property | Value | Reference |
|---|
| Melting Point | Not Available | Not Available | | Boiling Point | Not Available | Not Available | | Water Solubility | Not Available | Not Available | | LogP | -2.69 | Extrapolated |
|
|---|
| Experimental Chromatographic Properties | Not Available |
|---|
| Predicted Molecular Properties | |
|---|
| Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Retention Times Underivatized| Chromatographic Method | Retention Time | Reference |
|---|
| Measured using a Waters Acquity ultraperformance liquid chromatography (UPLC) ethylene-bridged hybrid (BEH) C18 column (100 mm × 2.1 mm; 1.7 μmparticle diameter). Predicted by Afia on May 17, 2022. Predicted by Afia on May 17, 2022. | 1.52 minutes | 32390414 | | Predicted by Siyang on May 30, 2022 | 9.7406 minutes | 33406817 | | Predicted by Siyang using ReTip algorithm on June 8, 2022 | 7.67 minutes | 32390414 | | AjsUoB = Accucore 150 Amide HILIC with 10mM Ammonium Formate, 0.1% Formic Acid | 223.1 seconds | 40023050 |
Predicted Kovats Retention IndicesUnderivatizedDerivatized| Derivative Name / Structure | SMILES | Kovats RI Value | Column Type | Reference |
|---|
| Leucyl-Glycine,1TMS,isomer #1 | CC(C)CC(N)C(=O)NCC(=O)O[Si](C)(C)C | 1714.0 | Semi standard non polar | 33892256 | | Leucyl-Glycine,1TMS,isomer #2 | CC(C)CC(N[Si](C)(C)C)C(=O)NCC(=O)O | 1741.4 | Semi standard non polar | 33892256 | | Leucyl-Glycine,1TMS,isomer #3 | CC(C)CC(N)C(=O)N(CC(=O)O)[Si](C)(C)C | 1707.7 | Semi standard non polar | 33892256 | | Leucyl-Glycine,2TMS,isomer #1 | CC(C)CC(N[Si](C)(C)C)C(=O)NCC(=O)O[Si](C)(C)C | 1771.6 | Semi standard non polar | 33892256 | | Leucyl-Glycine,2TMS,isomer #1 | CC(C)CC(N[Si](C)(C)C)C(=O)NCC(=O)O[Si](C)(C)C | 1759.9 | Standard non polar | 33892256 | | Leucyl-Glycine,2TMS,isomer #2 | CC(C)CC(N)C(=O)N(CC(=O)O[Si](C)(C)C)[Si](C)(C)C | 1714.4 | Semi standard non polar | 33892256 | | Leucyl-Glycine,2TMS,isomer #2 | CC(C)CC(N)C(=O)N(CC(=O)O[Si](C)(C)C)[Si](C)(C)C | 1779.7 | Standard non polar | 33892256 | | Leucyl-Glycine,2TMS,isomer #3 | CC(C)CC(C(=O)NCC(=O)O)N([Si](C)(C)C)[Si](C)(C)C | 1927.3 | Semi standard non polar | 33892256 | | Leucyl-Glycine,2TMS,isomer #3 | CC(C)CC(C(=O)NCC(=O)O)N([Si](C)(C)C)[Si](C)(C)C | 1784.3 | Standard non polar | 33892256 | | Leucyl-Glycine,2TMS,isomer #4 | CC(C)CC(N[Si](C)(C)C)C(=O)N(CC(=O)O)[Si](C)(C)C | 1793.9 | Semi standard non polar | 33892256 | | Leucyl-Glycine,2TMS,isomer #4 | CC(C)CC(N[Si](C)(C)C)C(=O)N(CC(=O)O)[Si](C)(C)C | 1787.1 | Standard non polar | 33892256 | | Leucyl-Glycine,3TMS,isomer #1 | CC(C)CC(C(=O)NCC(=O)O[Si](C)(C)C)N([Si](C)(C)C)[Si](C)(C)C | 1912.2 | Semi standard non polar | 33892256 | | Leucyl-Glycine,3TMS,isomer #1 | CC(C)CC(C(=O)NCC(=O)O[Si](C)(C)C)N([Si](C)(C)C)[Si](C)(C)C | 1880.7 | Standard non polar | 33892256 | | Leucyl-Glycine,3TMS,isomer #2 | CC(C)CC(N[Si](C)(C)C)C(=O)N(CC(=O)O[Si](C)(C)C)[Si](C)(C)C | 1781.8 | Semi standard non polar | 33892256 | | Leucyl-Glycine,3TMS,isomer #2 | CC(C)CC(N[Si](C)(C)C)C(=O)N(CC(=O)O[Si](C)(C)C)[Si](C)(C)C | 1851.1 | Standard non polar | 33892256 | | Leucyl-Glycine,3TMS,isomer #3 | CC(C)CC(C(=O)N(CC(=O)O)[Si](C)(C)C)N([Si](C)(C)C)[Si](C)(C)C | 1923.8 | Semi standard non polar | 33892256 | | Leucyl-Glycine,3TMS,isomer #3 | CC(C)CC(C(=O)N(CC(=O)O)[Si](C)(C)C)N([Si](C)(C)C)[Si](C)(C)C | 1905.5 | Standard non polar | 33892256 | | Leucyl-Glycine,4TMS,isomer #1 | CC(C)CC(C(=O)N(CC(=O)O[Si](C)(C)C)[Si](C)(C)C)N([Si](C)(C)C)[Si](C)(C)C | 1960.5 | Semi standard non polar | 33892256 | | Leucyl-Glycine,4TMS,isomer #1 | CC(C)CC(C(=O)N(CC(=O)O[Si](C)(C)C)[Si](C)(C)C)N([Si](C)(C)C)[Si](C)(C)C | 1980.6 | Standard non polar | 33892256 | | Leucyl-Glycine,1TBDMS,isomer #1 | CC(C)CC(N)C(=O)NCC(=O)O[Si](C)(C)C(C)(C)C | 1968.2 | Semi standard non polar | 33892256 | | Leucyl-Glycine,1TBDMS,isomer #2 | CC(C)CC(N[Si](C)(C)C(C)(C)C)C(=O)NCC(=O)O | 1989.9 | Semi standard non polar | 33892256 | | Leucyl-Glycine,1TBDMS,isomer #3 | CC(C)CC(N)C(=O)N(CC(=O)O)[Si](C)(C)C(C)(C)C | 1941.7 | Semi standard non polar | 33892256 | | Leucyl-Glycine,2TBDMS,isomer #1 | CC(C)CC(N[Si](C)(C)C(C)(C)C)C(=O)NCC(=O)O[Si](C)(C)C(C)(C)C | 2215.0 | Semi standard non polar | 33892256 | | Leucyl-Glycine,2TBDMS,isomer #1 | CC(C)CC(N[Si](C)(C)C(C)(C)C)C(=O)NCC(=O)O[Si](C)(C)C(C)(C)C | 2144.0 | Standard non polar | 33892256 | | Leucyl-Glycine,2TBDMS,isomer #2 | CC(C)CC(N)C(=O)N(CC(=O)O[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 2172.6 | Semi standard non polar | 33892256 | | Leucyl-Glycine,2TBDMS,isomer #2 | CC(C)CC(N)C(=O)N(CC(=O)O[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 2163.1 | Standard non polar | 33892256 | | Leucyl-Glycine,2TBDMS,isomer #3 | CC(C)CC(C(=O)NCC(=O)O)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 2361.1 | Semi standard non polar | 33892256 | | Leucyl-Glycine,2TBDMS,isomer #3 | CC(C)CC(C(=O)NCC(=O)O)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 2175.1 | Standard non polar | 33892256 | | Leucyl-Glycine,2TBDMS,isomer #4 | CC(C)CC(N[Si](C)(C)C(C)(C)C)C(=O)N(CC(=O)O)[Si](C)(C)C(C)(C)C | 2250.5 | Semi standard non polar | 33892256 | | Leucyl-Glycine,2TBDMS,isomer #4 | CC(C)CC(N[Si](C)(C)C(C)(C)C)C(=O)N(CC(=O)O)[Si](C)(C)C(C)(C)C | 2167.9 | Standard non polar | 33892256 | | Leucyl-Glycine,3TBDMS,isomer #1 | CC(C)CC(C(=O)NCC(=O)O[Si](C)(C)C(C)(C)C)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 2558.3 | Semi standard non polar | 33892256 | | Leucyl-Glycine,3TBDMS,isomer #1 | CC(C)CC(C(=O)NCC(=O)O[Si](C)(C)C(C)(C)C)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 2438.8 | Standard non polar | 33892256 | | Leucyl-Glycine,3TBDMS,isomer #2 | CC(C)CC(N[Si](C)(C)C(C)(C)C)C(=O)N(CC(=O)O[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 2444.5 | Semi standard non polar | 33892256 | | Leucyl-Glycine,3TBDMS,isomer #2 | CC(C)CC(N[Si](C)(C)C(C)(C)C)C(=O)N(CC(=O)O[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 2415.4 | Standard non polar | 33892256 | | Leucyl-Glycine,3TBDMS,isomer #3 | CC(C)CC(C(=O)N(CC(=O)O)[Si](C)(C)C(C)(C)C)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 2583.3 | Semi standard non polar | 33892256 | | Leucyl-Glycine,3TBDMS,isomer #3 | CC(C)CC(C(=O)N(CC(=O)O)[Si](C)(C)C(C)(C)C)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 2459.5 | Standard non polar | 33892256 | | Leucyl-Glycine,4TBDMS,isomer #1 | CC(C)CC(C(=O)N(CC(=O)O[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 2807.3 | Semi standard non polar | 33892256 | | Leucyl-Glycine,4TBDMS,isomer #1 | CC(C)CC(C(=O)N(CC(=O)O[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 2706.3 | Standard non polar | 33892256 |
|
|---|
| Disease References | | Colorectal cancer |
|---|
- Brown DG, Rao S, Weir TL, O'Malia J, Bazan M, Brown RJ, Ryan EP: Metabolomics and metabolic pathway networks from human colorectal cancers, adjacent mucosa, and stool. Cancer Metab. 2016 Jun 6;4:11. doi: 10.1186/s40170-016-0151-y. eCollection 2016. [PubMed:27275383 ]
- Sinha R, Ahn J, Sampson JN, Shi J, Yu G, Xiong X, Hayes RB, Goedert JJ: Fecal Microbiota, Fecal Metabolome, and Colorectal Cancer Interrelations. PLoS One. 2016 Mar 25;11(3):e0152126. doi: 10.1371/journal.pone.0152126. eCollection 2016. [PubMed:27015276 ]
- Goedert JJ, Sampson JN, Moore SC, Xiao Q, Xiong X, Hayes RB, Ahn J, Shi J, Sinha R: Fecal metabolomics: assay performance and association with colorectal cancer. Carcinogenesis. 2014 Sep;35(9):2089-96. doi: 10.1093/carcin/bgu131. Epub 2014 Jul 18. [PubMed:25037050 ]
| | Periodontal Probing Depth |
|---|
- Liebsch C, Pitchika V, Pink C, Samietz S, Kastenmuller G, Artati A, Suhre K, Adamski J, Nauck M, Volzke H, Friedrich N, Kocher T, Holtfreter B, Pietzner M: The Saliva Metabolome in Association to Oral Health Status. J Dent Res. 2019 Jun;98(6):642-651. doi: 10.1177/0022034519842853. Epub 2019 Apr 26. [PubMed:31026179 ]
|
|
|---|
| General References | - Fujii Y, Kiss T, Gajda T, Tan XS, Sato T, Nakano Y, Hayashi Y, Yashiro M: Copper(II)- cis, cis-1,3,5-triaminocyclohexane complex-promoted hydrolysis of dipeptides: kinetic, speciation and structural studies. J Biol Inorg Chem. 2002 Sep;7(7-8):843-51. Epub 2002 Apr 30. [PubMed:12203021 ]
- Yoshino AH, Okabayashi HF, Kanbe HH, Suzuki K, O'Connor CJ: Folded structures of L-leucylglycine oligopeptides and their aggregational behavior in aqueous solution: Raman scattering spectra and proton NMR spin-lattice relaxation studies. J Phys Chem B. 2008 May 8;112(18):5824-33. doi: 10.1021/jp074732q. Epub 2008 Apr 12. [PubMed:18407703 ]
- Nethery A, O'Grady RL: Interstitial collagenase from rat mammary carcinoma cells: interaction with substrates and inhibitors. Invasion Metastasis. 1991;11(5):241-8. [PubMed:1666066 ]
- Kiyotani T, Sugawara Y: L-Leucylglycine 0.67-hydrate and [(4S)-2,2-dimethyl-4-(2-methylpropyl)-5-oxoimidazolidin-3-ium-1-yl]acetate. Acta Crystallogr C. 2012 Dec;68(Pt 12):o498-501. doi: 10.1107/S010827011204810X. Epub 2012 Nov 28. [PubMed:23221255 ]
- Xia T, Akers K, Eisen AZ, Seltzer JL: Comparison of cleavage site specificity of gelatinases A and B using collagenous peptides. Biochim Biophys Acta. 1996 Apr 16;1293(2):259-66. [PubMed:8620038 ]
- Suzuki H, Kamatani S, Kumagai H: Purification and characterization of aminopeptidase B from Escherichia coli K-12. Biosci Biotechnol Biochem. 2001 Jul;65(7):1549-58. [PubMed:11515538 ]
|
|---|